Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Higher Diversity of Gut Microbes, More Faecalibacteria Linked to Better Response to Cancer Immunotherapy, Study Shows
The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter Parker Institute @parkerici RT @nikeshk: Help us turn cancer into a curable disease! https://t.co/CNzh0JVjzX 21 hours ago
Open in Twitter Parker Institute @parkerici RT @TheVinodLab: @nature papers on neoantigen qualities in long-term #pancreaticcancer survivors and in #Immunotherapy 2nd and 4th highest… 2 days ago